Skip to main content
eScholarship
Open Access Publications from the University of California

Drug costs of Medicaid-covered therapies for pemphigus vulgaris treatment

  • Author(s): Hauptman, Megan
  • Krase, Jeffrey M
  • et al.
Creative Commons 'BY-NC-ND' version 4.0 license
Abstract

Pemphigus vulgaris is the most common form of pemphigus affecting an estimated 30,000-40,000 people in the United States. Costs of systemic and immunoglobulin therapies for pemphigus vulgaris have remained persistently high. Herein, we address the current costs and changes in costs of immunosuppressive treatments, anti-inflammatory treatments, and immunoglobulin treatments covered by Medicaid for pemphigus vulgaris from 2013-2020.

Main Content
Current View